11 publications
9 publications
6 publications
4 publications
2 publications
2 publications
2 publications
2 publications
2 publications
1 publication
1 publication
1 publication
1 publication
1 publication
1 publication
BCTRIMS 2024
The long Journey to achieve high efficacy therapy – Alemtuzumab in Brazilian public scenario
BCTRIMS 2024
Real-world experience with patient laboratory monitoring compliance during Alemtuzumab treatment in a low-income country: A pilot descriptive study
BCTRIMS 2024
Cytokine Storms during Alemtuzumab Infusion: A case series
BCTRIMS 2024
Hyperkeratotic lesions associated to Natalizumab treatment for multiple sclerosis: Case report and literature review
BCTRIMS 2024
Title: Early Relapse after Alemtuzumab treatment: A Case Report of Highly Active Multiple Sclerosis
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper